Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: "cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer. | Radiation Oncology BioMed Central Open Access cExternal beam radiation results in minimal changes in post void residual urine volumes during the treatment of clinically localized prostate cancer Peter F Orio III1 Gregory S Merrick 2 Zachariah A Allen2 Wayne M Butler2 Kent E Wallner3 Brian S Kurko2 and Robert W Galbreath2 Address 1Brooke Army Medical Center Department of Radiation Oncology Ft. Sam Houston TX 78234 USA 2Schiffler Cancer Center and Wheeling Jesuit University 1 Medical Park Wheeling WV 26003 USA and 3Puget Sound Healthcare Corporation Group Health Cooperative University of Washington Seattle WA 98108 USA Email Peter F Orio - peter.orio@us.army.mil Gregory S Merrick - gmerrick@urologicresearchinstitute.org Zachariah A Allen - zallen@urologicresearchinstitute.org Wayne M Butler - wbutler@urologicresearchinstitute.org Kent E Wallner - kent.wallner@med.va.gov Brian S Kurko - bkurko@wheelinghospital.org Robert W Galbreath - rgalbrea@wju.edu Corresponding author Published 22 July 2009 Received 9 April 2009 Radiation Oncology 2009 4 26 doi 10.1186 1748-717X-4-26 Accepted 22 July 2009 This article is available from http www.ro-journal.cOm content 4 1 26 2009 Orio et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background To evaluate the impact of external beam radiation therapy XRT on weekly ultrasound determined post-void residual PVR urine volumes in patients with prostate cancer. Methods 125 patients received XRT for clinically localized prostate cancer. XRT was delivered to the prostate only n 66 or if the risk of lymph node involvement was greater than 10 to the whole pelvis followed by a prostate boost n 59 . All patients were irradiated in the prone position in a custom hip-fix mobilization device
